Mannan-binding lectin deficiency increases the risk of recurrent infections in children with Down's syndrome

Human Immunology

Volumn 71, Issue 1, 2010, Pages 63-66

  Nisihara, Renato M ^a,b   Utiyama, Shirley R R ^a   Oliveira, Nanci P ^a   Messias Reason, Iara J ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b University Evangelic Hospital   (Brazil)

Author keywords

Complement; Down's syndrome; Immunocompromised children; MBL deficiency; Pneumonia; Recurrent infections

Indexed keywords

MANNAN BINDING LECTIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN SYNDROME; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; RECURRENT INFECTION; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; BRAZIL; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; MANNOSE-BINDING LECTIN; RECURRENCE; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 71249116003     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.09.361     Document Type: Article

References (34)

1. Cuadrado E., and Barrena M.J. Immune dysfunction in Down's syndrome: Primary immune deficiency or early senescence of the immune system?. Clin Immunol Immunopathol 78 (1996) 209-214
2. Day S.M., Strauss D.J., Shavelle R.M., and Reynols R.J. Mortality and causes oh death in persons with Down syndrome in California. Dev Med Child Neurol 47 (2005) 171-176
3. Hill D.A., Gridley G., Cnattingius S., Mellemkjaer L., Linet M., Adami H.O., et al. Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med 163 (2003) 705-711
4. Janeway A., Travers P., and Walport M.J. Immunobiology. 6th ed. (2007), Artmed, Porto Alegre, Brazil
5. Turner M.W. Mannan-binding lectin (MBL) in health and disease. Immunobiology 199 (1998) 327-339
6. Turner M.W. The role of mannose binding lectin in health and disease. Mol Immunol 40 (2003) 423-429
7. Shi L., Takahashi K., Dundee J., Shahroor-Karni S., Thiel S., Jensenius J.C., et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 199 (2004) 1379-1390
8. Stuart L.M., Takahashi K., Shi L., Savill J., and Ezekowitz R.A. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol 174 (2005) 3220-3226
9. Eisen D.P., and Minchinton R.M. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 37 (2003) 1496-1505
10. Thiel S., Frederiksen P.D., and Jensenius J.C. Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol 43 (2006) 86-96
11. Schafranski M.D., Stier A., Nisihara R., and Messias-Reason I.J. Significantly increased levels of mannose-binding lectin (MBL) in rheumatic heart disease: A beneficial role for MBL deficiency. Clin Exp Immunol 138 (2004) 521-525
12. Hansen T.K., Thiel S., Knudsen S.T., Gravholt C.H., Christiansen J.S., Mogensen C.E., et al. Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J Clin Endocrinol Metab 88 (2003) 4857-4861
13. Messias Reason I.J., Schafranski M.D., Jensenius J.C., and Steffensen R. The association between mannose-binding lectin gene polymorphism and rheumatic heart disease. Hum Immunol 67 (2006) 991-998
14. Santos I.K., Costa C.H., Krieger H., Feitosa M.F., Zurakowski D., Fardin B., et al. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun 69 (2001) 5212-5215
15. Dornelles L.N., Pereira-Ferrari L., and Messias-Reason I. Mannan-binding lectin plasma levels in leprosy: Deficiency confers protection against the lepromatous but not the tuberculoid forms. Clin Exp Immunol 145 (2006) 463-468
16. Messias-Reason I.J., Boldt A.B., Braga M., Rosen V., Seeling Stahlke E., Dornelles L., et al. The association between mannan-binding lectin gene polymorphism and clinical leprosy: New insight into an old paradigm. J Infect Dis 196 (2007) 1379-1385
17. Garred P., Larsen F., Madsen H.O., and Koch C. Mannose-binding lectin deficiency-revisited. Mol Immunol 40 (2003) 73-84
18. Petersen K.A., Matthiesen F., Agger T., Kongerslev L., Thiel S., Cornelissen K., and Axelsen M. Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin. J Clin Immunol 26 (2006) 465-475
19. Graham N.M. The epidemiology of acute respiratory infections in children and adults: A global perspective. Epidemiol Rev 12 (1990) 149-178
20. Selwyn B.J. The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Coordinated Data Group of BOSTID Researchers. Rev Infect Dis 12 Suppl 8 (1990) S870-S888
21. Koch A., Melbye M., Sorensen P., Homoe P., Madsen H.O., Molbak K., et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. J Am Med Assoc 14 (2001) 1316-1318
22. Cedzynski M., Szemraj J., Swierzko A.S., Bak-Romaniszyn L., Banasik M., Zeman K., and Kilpatrick D.C. Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol 136 (2004) 304-311
23. Pereira C.A.C., Carvalho C.R.R., Pereira-Silva J.L., Dalcolmo M.M.P., and Messeder O.H.C. Pneumonia adquirida na comunidade. Consenso Bras Pneumonias J Pneumol 27 (2001) 13-21
24. Van Emmerik L.C., Kuijper E.J., Fijen C.A., Dankert J., and Thiel S. Binding of Mannan-binding protein to various bacterial pathogens of meningitis. Clin Exp Immunol 97 (1994) 411-416
25. Eisen D.P., Dean M.M., Boermeester M.A., Fidler K.J., Gordon A.C., Kronborg G., et al. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis 47 (2008) 510-516
26. Hingh Y., Van der Vossen P., and Gemen E. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr 147 (2005) 744-747
27. Sørensen C.M., Hansen T.K., Steffensen R., Jensenius J.C., and Thiel S. Hormonal regulation of mannan-binding lectin synthesis in hepatocytes. Clin Exp Immunol 145 (2006) 173-182
28. Murphy M., Friend D., and Pike-Nobile L. Tumor necrosis factor alpha and IFN-gamma expression in human thymus. J Immunol 149 (1992) 2506-2512
29. Schlapbach L.J., Aebi C., Otth M., Luethy A.R., Leibundgut K., Hirt A., and Ammann R.A. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients. Pediatr Blood Cancer 49 (2007) 11-16
30. Peterslund N.A., Koch C., Jensenius J.C., and Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 25 (2001) 637-638
31. Vekemans M., Robinson J., Georgala A., Heymans C., Muanza F., Paesmans M., et al. Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy. Clin Infect Dis 44 (2007) 1593-1601
32. Summerfield J.A. Clinical potential of mannose-binding lectin-replacement therapy. Biochem Soc Trans 31 (2003) 770-773
33. Valdimarsson H. Infusion of plasma-derived mannan-binding lectin (MBL) into MBL-deficient humans. Biochem Soc Trans 3 (2003) 768-769
34. Frakking F.N., Brouwer N., van de Wetering M.D., Budde I.K., Strengers P.F., Huitema A.D., et al. Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia. Eur J Cancer 45 (2009) 505-512